- All sections
- C - Chemistry; metallurgy
- C07J - Steroids
- C07J 5/00 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom
Patent holdings for IPC class C07J 5/00
Total number of patents in this class: 251
10-year publication summary
21
|
22
|
10
|
25
|
26
|
20
|
16
|
19
|
14
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Sage Therapeutics, Inc. | 349 |
35 |
Cassiopea S.P.A. | 45 |
9 |
Cosmo Technologies Limited | 115 |
9 |
ReveraGen Biopharma, Inc. | 30 |
9 |
Ripple Therapeutics Corporation | 31 |
8 |
Neurmedix Inc. | 16 |
7 |
The University of British Columbia | 1468 |
6 |
BIOVIE, Inc. | 27 |
6 |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 275 |
5 |
Shanghai Hansoh Biomedical Co., Ltd. | 229 |
5 |
Allergan Sales, LLC | 257 |
4 |
Richter Gedeon Nyrt. | 1512 |
4 |
Washington University | 1542 |
4 |
Coral Drugs Pvt. Ltd. | 5 |
4 |
Farmabios S.p.A. | 18 |
3 |
Interface Biologics Inc. | 39 |
3 |
Santen Pharmaceutical Co., Ltd. | 625 |
3 |
Umecrine Cognition AB | 23 |
3 |
Allergan, Inc. | 2438 |
2 |
Acerus Pharmaceuticals Corporation | 2 |
2 |
Other owners | 120 |